Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients

Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients

Background: Aromatase inhibitors-related musculoskeletal syndrome (AIMSS) is a common side effect experienced by early breast cancer patients undergoing endocrine therapy. This condition can result in medication discontinuation and a diminished quality of life. The objective of this study was to cha...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng Jing, Lingyun Jiang, Yuling Cao, Maoting Tian, Jiajia Qiu, Jing Zhang, Lichen Tang, Renquan Lu, Yan Hu
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Metabolites
Subjects:
breast neoplasms
aromatase inhibitors
musculoskeletal symptoms
proteomics
metabolomics
biomarkers
Online Access:https://www.mdpi.com/2218-1989/15/3/153
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2218-1989/15/3/153

Similar Items